NUKL.DE vs. NOVO-B.CO
NUKL.DE (VanEck Uranium and Nuclear Technologies UCITS ETF A) is Energy Equities fund tracking the MarketVector Global Uranium and Nuclear Energy Infrastructure, while NOVO-B.CO (Novo Nordisk A/S) is a stock. Over the past 3 years, NUKL.DE returned 41.91%/yr vs 4.37%/yr for NOVO-B.CO. At a 0.16 correlation, their price movements are largely independent.
Performance
NUKL.DE vs. NOVO-B.CO - Performance Comparison
Loading charts...
Different Trading Currencies
NUKL.DE is traded in EUR, while NOVO-B.CO is traded in DKK. To make them comparable, the NOVO-B.CO values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, NUKL.DE achieves a 11.67% return, which is significantly higher than NOVO-B.CO's -8.77% return.
NUKL.DE
- 1D
- 0.87%
- 1M
- -2.14%
- YTD
- 11.67%
- 6M
- 10.58%
- 1Y
- 37.70%
- 3Y*
- 41.91%
- 5Y*
- —
- 10Y*
- —
NOVO-B.CO
- 1D
- 1.61%
- 1M
- -4.08%
- YTD
- -8.77%
- 6M
- -7.60%
- 1Y
- -42.25%
- 3Y*
- 4.37%
- 5Y*
- 20.51%
- 10Y*
- 17.26%
NUKL.DE vs. NOVO-B.CO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
NUKL.DE VanEck Uranium and Nuclear Technologies UCITS ETF A | 11.67% | 51.50% | 38.03% | 23.67% |
NOVO-B.CO Novo Nordisk A/S | -8.77% | -46.44% | -9.91% | 195.87% |
Correlation
The correlation between NUKL.DE and NOVO-B.CO is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Feb 8, 2023 | 0.16 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NUKL.DE vs. NOVO-B.CO — Risk / Return Rank
NUKL.DE
NOVO-B.CO
NUKL.DE vs. NOVO-B.CO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Uranium and Nuclear Technologies UCITS ETF A (NUKL.DE) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NUKL.DE | NOVO-B.CO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.00 | ||
| Sortino ratioReturn per unit of downside risk | +2.72 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 0.87 | +0.34 |
| Calmar ratioReturn relative to maximum drawdown | 1.86 | -0.78 | +2.65 |
| Martin ratioReturn relative to average drawdown | 4.43 | -1.15 | +5.59 |
Loading charts...
Drawdowns
NUKL.DE vs. NOVO-B.CO - Drawdown Comparison
The maximum NUKL.DE drawdown since its inception was -37.52%, smaller than the maximum NOVO-B.CO drawdown of -76.81%. Use the drawdown chart below to compare losses from any high point for NUKL.DE and NOVO-B.CO.
Loading charts...
Drawdown Indicators
| NUKL.DE | NOVO-B.CO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -37.52% | -76.81% | +39.29% |
Max Drawdown (1Y)Largest decline over 1 year | -27.12% | -54.72% | +27.60% |
Max Drawdown (3Y)Largest decline over 3 years | -37.52% | -76.81% | +39.29% |
Max Drawdown (5Y)Largest decline over 5 years | — | -76.81% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -76.81% | — |
Current DrawdownCurrent decline from peak | -12.83% | -70.26% | +57.43% |
Average DrawdownAverage peak-to-trough decline | -7.79% | -11.90% | +4.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.43% | 37.20% | -25.77% |
Volatility
NUKL.DE vs. NOVO-B.CO - Volatility Comparison
VanEck Uranium and Nuclear Technologies UCITS ETF A (NUKL.DE) and Novo Nordisk A/S (NOVO-B.CO) have volatilities of 11.05% and 11.47%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NUKL.DE | NOVO-B.CO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.05% | 11.47% | -0.42% |
Volatility (6M)Calculated over the trailing 6-month period | 28.97% | 39.57% | -10.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.82% | 54.44% | -12.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 34.22% | 58.61% | -24.39% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.22% | 45.19% | -10.97% |
Dividends
NUKL.DE vs. NOVO-B.CO - Dividend Comparison
NUKL.DE has not paid dividends to shareholders, while NOVO-B.CO's dividend yield for the trailing twelve months is around 4.07%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NOVO-B.CO Novo Nordisk A/S | 4.07% | 3.58% | 1.59% | 1.01% | 2.38% | 2.54% | 4.03% | 4.22% | 5.27% | 4.54% | 7.38% | 2.50% |
NUKL.DE VanEck Uranium and Nuclear Technologies UCITS ETF A | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
NUKL.DE and NOVO-B.CO have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for NUKL.DE and NOVO-B.CO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer